Logo 2839 Logo 2839 (Fenofibric Acid Delayed-Release 135 mg)
Pill with imprint Logo 2839 Logo 2839 is Brown & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Actavis Pharma, Inc.
Fenofibric acid is used in the treatment of high cholesterol; hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 2839 Logo 2839
Fenofibric Acid Delayed-Release
- Imprint
- Logo 2839 Logo 2839
- Strength
- 135 mg
- Color
- Brown & Yellow
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00228-2839 (Discontinued)
- Inactive Ingredients
-
ammonio methacrylate copolymer type A,
ammonio methacrylate copolymer type B,
hydroxypropyl cellulose (type l),
sodium lauryl sulfate,
sucrose,
corn starch,
magnesium silicate,
triethyl citrate,
gelatin,
titanium dioxide,
ferric oxide yellow,
ferrosoferric oxide,
potassium hydroxide,
propylene glycol,
shellac,
ammonia,
ferric oxide red
Note: Inactive ingredients may vary.
More about fenofibric acid
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (25)
- Drug images
- Pricing & coupons
- En español
- Drug class: fibric acid derivatives
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.